The Rise of Molecules Able To Regenerate the Central Nervous System

Area of Science:

• Neuroscience
• Regenerative Medicine
• Pharmacology

Background:

• Adult central nervous system (CNS) injuries result in persistent functional impairments.
• Limited axonal regeneration in the CNS hinders functional recovery after injury.
• Complexity of axonal regeneration mechanisms has historically impeded drug discovery.

Purpose of the Study:

• To review the development of drugs targeting CNS regeneration.
• To discuss biological assays and screening methods for identifying regenerative drugs.
• To highlight key challenges in CNS drug discovery for axonal regeneration.

Main Methods:

• Automated screening techniques to evaluate molecules for axonal regrowth stimulation.
• Biological assays designed to test CNS drug candidates.
• Review of significant high-throughput screening campaigns.

Main Results:

• Identification of numerous molecular hits that stimulate axonal regeneration.
• Discovery of novel biological mechanisms underlying axonal regrowth.
• Advancements in drug discovery for CNS repair.

Conclusions:

• The field of CNS regenerative drugs has advanced significantly.
• Automated screening has accelerated the identification of potential therapeutic agents.
• Overcoming challenges in vivo is critical for translating regenerative drugs into clinical applications.